Home › Grants › United States › Renewal Application: Kidney Health Initiative (R18) Clinical Trials Op

Renewal Application: Kidney Health Initiative (R18) Clinical Trials Optional

The Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Office of New Drugs (OND) is announcing its intent to accept and consider continuation of the award of a grant to the American Society of Nephrology (ASN) to support the Kidney Health Initiative (KHI).

Grant (non-repayable) Intake closed; program continues (check for next intake)

Funder

Food and Drug Administration
Funder profile and all of its programs

Amount

Up to $350,000 per award; $350,000 total program funding (estimated) (published on Grants.gov for the latest cycle).

Where

United States (federal)

Eligibility

Eligible applicant types are set out on the official page. No cost sharing is required. Recurring: posted in 2 different years; this cycle has closed, watch for the next one.

Sectors

Agriculture and agri-food, Health and life sciences, Research and science

Deadline

Varies: check the official page for current dates

Source

Grants.gov XML extract (RFA-FD-24-041)

Last checked

2 November 2026

Funder contacts

Public organizational contacts on file Unlock full profile / Sign up

Official page ↗

From official open data: listed in the official Grants.gov extract on 2026-11-02. The summary is from the official listing; the eligibility line is our plain-language reading of its eligibility codes. Confirm details on the official page.

Related grant lists

Agriculture and agri-food Health and life sciences Research and science Nonprofits and charities United States United States (national) Federal agency $100,000 to $500,000

Information only. GrantSift is not affiliated with any funder. A match means a program is likely eligible or worth checking, not that you will be funded. Always confirm details on the official page. Applying through official portals is free.